RAYNER GROUP – MODERN SLAVERY ACT 2015 STATEMENT
Rayner Surgical Group Limited is the parent company in the Rayner group of companies (‘Rayner’). Rayner is a British manufacturer and global supplier of medical devices in the ophthalmology sector. Rayner has over 300 employees worldwide and operates in numerous countries across the globe.
Our business has its headquarters in Worthing (UK) which hosts our central functions including manufacturing, marketing, IT, quality assurance, regulatory affairs, supply chain, HR, finance and legal departments. We have direct subsidiaries in Germany, Spain, Portugal, Italy and USA through which we operate our business at a local level.
OUR SUPPLY CHAINS
As a business that develops, manufactures and sells medical devices, we procure a wide range of goods and services to support the delivery of our business strategy. We consider the highest potential risk areas in relation to modern slavery are in our supply chain. To mitigate the risks that could be associated with our business and our supply chain, Rayner has in place policies, procedures and processes which seek to avoid incidences of modern slavery and human trafficking.
RAYNER POLICY AND SUPPLIER ADHERENCE TO OUR VALUES
The Rayner Group Labour Standards Policy reflects our commitment to acting ethically and with integrity in all our business relationships. To achieve this, we seek to implement and enforce effective systems and controls, designed to ensure slavery and human trafficking is not taking place either in our business or within our wider supply chain.
We expect our suppliers to share this commitment to labour standards, human rights and ethical conduct; accordingly, we require that they conduct their employment and business practices in full compliance with all applicable laws and regulations.
DUE DILIGENCE PROCESSES FOR COMBATING SLAVERY AND HUMAN TRAFFICKING
Rayner has a formal supplier approval process to support the business in minimising risk when procuring goods and services. This is supported by Quality Assurance Audits which specifically address modern slavery and human trafficking. Should we believe that a supplier is not undertaking adequate action to prevent modern slavery or human trafficking, or is acting in breach of Rayner’s policies, the relationship with the supplier would be investigated and, if deemed appropriate, terminated.
We also provide a confidential whistleblowing hotline which allows our employees and third parties to report any suspicions of slavery within our operations. Any such reports are promptly investigated and we are committed to effectively addressing any issues we find which may include the termination of our relationship with a supplier or others with whom we do business.
In the spirit of continuous improvement, Rayner is looking to enhance its labour standards processes and procedures through:
- Improved identification and assessment of potential risk areas in our supply chains and our wider business;
- Monitoring of potential risk areas in our supply chains and wider business and improved follow-up procedures;
- Provision of effective, tailored training to our procurement and supplier-facing staff on modern slavery / labour standards.
- Effective investigation and elimination of wrong-doing within our organisation and effective communication and enforcement of our policies and standards amongst our suppliers and others with whom we do business.
This statement is made in accordance with Section 54(1) of the Modern Slavery Act 2015 (the ‘Act’) and constitutes the Modern Slavery and Human Trafficking Statement for the Rayner Group for the financial year ending 31 December 2018. It was signed on behalf of the Board by:
Chief Executive Officer
Rayner Surgical Group Limited